Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24.7M
-
Number of holders
-
246
-
Total 13F shares, excl. options
-
21.6M
-
Shares change
-
+854K
-
Total reported value, excl. options
-
$3.56B
-
Value change
-
+$101M
-
Put/Call ratio
-
0.17
-
Number of buys
-
120
-
Number of sells
-
-134
-
Price
-
$164.39
Significant Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q2 2022
309 filings reported holding ICUI - ICU MEDICAL INC/DE - Common Stock as of Q2 2022.
ICU MEDICAL INC/DE - Common Stock (ICUI) has 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.6M shares
of 24.7M outstanding shares and own 87.54% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (2.71M shares), JANUS HENDERSON GROUP PLC (2.55M shares), VANGUARD GROUP INC (2.08M shares), WELLINGTON MANAGEMENT GROUP LLP (1.83M shares), BlackRock Inc. (1.74M shares), NUANCE INVESTMENTS, LLC (1.01M shares), JPMORGAN CHASE & CO (759K shares), STATE STREET CORP (558K shares), SEGALL BRYANT & HAMILL, LLC (372K shares), and ATLANTA CAPITAL MANAGEMENT CO L L C (363K shares).
This table shows the top 246 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.